Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

NCT04795141 is registered in ClinicalTrials.gov with Inmagene LLC as lead sponsor.

NCT NCT04795141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
Lead sponsor
Inmagene LLC
Phase
Phase 2
Overall status
Terminated
Start date
August 24, 2021
Completion date
August 30, 2022
Enrollment
25 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis